"Taking in consideration that I am not a medical professional but just a patient with no knowledge of cancer treatment and surgery, I consider her to be top notch. Dr. Scalici was very thorough with providing information and care. I would highly recommend her service and her surgery skills."
"So glad my obgyn in Daphne referred me to Dr. Scalici."
"I have never been treated so thoroughly. I absolutely love Dr. Scalici and her wonderful PA."
Jennifer Scalici, M.D., joined Mitchell Cancer Institute (MCI) in 2012 after completing a fellowship in gynecologic oncology at the University of Virginia. As a fellow, she developed an investigator-initiated clinical trial evaluating the use of a novel biomarker for ovarian cancer.
Upon her arrival at MCI, she built a busy clinical practice with an emphasis on minimally invasive and robotic surgery. She is currently participating in research to evaluate a novel, minimally invasive procedure to improve the prognostic value and decrease the morbidity of lymph node dissections in gynecologic malignancies.
Dr. Scalici also continues to conduct basic and translational research in collaboration with other members of the MCI gynecologic team. Her active areas of interest are ovarian carcinogenesis and the development of a novel animal model of ovarian cancer with the goal of improving early detection and prevention strategies.
She is also evaluating the role of estrogen metabolism and obesity in the development of endometrial cancer. Dr. Scalici has presented five abstracts and three oral presentations at national meetings since her arrival at MCI, including a Poster of Exceptional Merit at the American College of Surgeons Annual Congress in 2013.
The 5K and 1-mile fun run benefit the institute’s ongoing gynecologic cancer research while showing support for patients and raising awareness about women’s reproductive cancers.
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other gynecologic cancer. Only about 20% of cases are diagnosed at an early stage, when the disease is more treatable.
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. Only about 20% of cases are diagnosed at an early stage, when ovarian cancer is more treatable.
Voting for this year’s awards starts Wednesday, May 3, at VoteNappies.com and runs through May 28.
Physician-scientist Jennifer M. Scalici, M.D., has been named the recipient of the 2021 Mayer Mitchell Award for Excellence in Cancer Research.
Scalici will oversee the day-to-day operations of the division, which employs five gynecologic oncologists, two nurse practitioners and their support staff, and is the largest gynecologic oncology practice on the upper Gulf Coast.
